Vrakidou Evfimia

Vrakidou Evfimia Hematologist

Education & Academic Qualifications

  • Gratuated From Medical School Of National And Kapodistrian University Of Athens

Education:

  • Hematologist (Specialised In ‘Evangelismos’ Hospital)

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Hellenic Society Of Hematology

  • American Society Of Hematology

  • European Hematology Association

Editorial Boards:
Ad-Hoc Reviewer For Peer-Reviewed International Journals

  • Co-Editor Of Pet/Ct In Lymphomas (Springer)

  • Leading Author Of 2 Chapters In Scientific Magazines (Concerning ‘’Lymphomas’’ And ‘’Mds’’) 

 

Work Experience

  • Associate Member In ‘’Hygeia’’ Hospital.

    • 1986-1990: Working As Independent Doctor Of ‘’Internal Medicine’’

    • 1990-1992: Doctor Of Internal Medicine- Hematologist In ‘’Bio-Check’’

    • 1991-2000: ‘’Hygeia’’ Hospital, Collaborator Hematologist In A. Papagiannis Team

    • 2000-Today: Associate Hematologist Having My Own Hematogical Team

  • Collaboration With Dr. A. Tefferi In Mayo Clinic Rochester

Education Experience:

  • Giving Courses To Post-Graduated Doctors

  • Participation As Tutor In Scientific Events In ‘’Sotiria’’ Hospital’’, ‘’Evangelismos’’ Hospital, ‘’Greek Association Of Pneumology’’,‘’Hygeia’’ Hospital

 

Clinical & Research Interest

Clinical Interest:

  • Leukemia

  • Lymphomas

  • Chronic Myeloproliferative Diseases

  • Thrombophilia

Research Interest:

  • Clinical Studies Concerning ‘’Chronic Lymphocytic Leukemia’’, ‘’Acute Leukemia’’, ‘’Lymphomas’’ (N.H.L. , Hodgkin), ‘’Multiple Myeloma’’, ‘’Myelosclerosis’’

  • Primary Investigator In International Protocols Concerning ‘’Resistant Cll’’ And ‘’Epo’’ 

 

Honors & Awards

  • Scientific Paper On: ‘’R-Chop On The Treatment Of Primary Mediastinal Lym-phoma’’ , Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone With Or Without Radiotherapy In Primary Mediastinal Large B-Cell Lympho-ma: The Emerging Standard Of Care. Pmid: 22282906

Recent Publications

  • Cytotoxic T Cell-Mediated Gastritis After Rituximab Treatment For Gastric Malt Lymphoma. Pmid : 23725385

  • Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone With Or Without Radiotherapy In Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard Of Care. Pmid: 22282906

  • Association Of Interleukin-1a, Interleukin-1b And Interleukin-1 Receptor An-tagonist Gene Polymorphisms With Multiple Myeloma. Pmid:17926179

  • Pure Infradiaphragmatic Hodgkin’s Lymphoma. Clinical Features, Prognostic Factor And Comparison With Supradiaphragmatic Disease. Pmid:16434368

  • A Randomized Trial Comparing Intensified Cnop Vs. Chop In Patients With Aggressive Non-Hodgkin’s Lymphoma. Pmid: 12769340